Colleen Kusy is a Baird Senior Research Analyst covering Biotechnology. Colleen joined Baird in 2014. Prior to her current role, she spent over six years as a sell-side associate covering biotechnology stocks across a range of therapeutic areas and market caps at Baird. She started her career in Fixed Income Capital Markets at Baird as a business analyst. Colleen received a BBA in Finance and a BA in French and Francophone Studies from Villanova University.